ACADIA Pharmaceuticals Inc (ACAD)

Gross profit margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Gross profit	US$ in thousands	875,956	680,706	507,069	465,004	421,205
Revenue	US$ in thousands	957,797	726,437	517,235	484,145	441,755
Gross profit margin		91.46%	93.70%	98.03%	96.05%	95.35%

December 31, 2024 calculation

Gross profit margin = Gross profit ÷ Revenue
= $875,956K ÷ $957,797K
= 91.46%

ACADIA Pharmaceuticals Inc has shown a consistently high gross profit margin over the years, starting at 95.35% in December 31, 2020, and peaking at 98.03% in December 31, 2022. This indicates the company's efficient management of production costs and pricing strategies to generate profits from sales. However, there was a slight decrease in the gross profit margin to 93.70% in December 31, 2023 and further down to 91.46% in December 31, 2024. While the margin remains relatively high compared to industry standards, the downward trend may suggest potential challenges in maintaining profitability or increased costs associated with the company's operations during those years. It would be crucial for stakeholders to closely monitor the trend and assess the underlying factors influencing the company's gross profit margin performance.